Literature DB >> 31254932

Charge-convertible polymers for improved tumor targeting and enhanced therapy.

Yi Li1, Hong Yu Yang2, Thavasyappan Thambi1, Jae-Hyung Park1, Doo Sung Lee3.   

Abstract

Charge-convertible polymers are a class of intelligent polymers that can convert their charges in response to a certain stimulus in their environment. This unique property endows charge-convertible polymer-based biomaterials with great advantages in the treatment of disease. Drug-loaded charge-convertible polymeric nanoparticles have the ability to target tumor cells by converting their surface charges from negative or neutral to positive at the tumor site. In addition, charge-convertible polymeric biomaterials can form complexes with negatively charged therapeutic agents and release them through charge conversion at the desired time and site. In this review, the properties of charge-convertible polymers and their applications in the treatment of cancer and stroke are covered. More importantly, the limitations and perspectives of charge-convertible polymeric biomaterials in future clinical applications are discussed.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Charge conversion; Polymeric biomaterials; Triggered release; Tumor targeting

Year:  2019        PMID: 31254932     DOI: 10.1016/j.biomaterials.2019.119299

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

Review 1.  Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases.

Authors:  Meihua Luo; Leo Kit Cheung Lee; Bo Peng; Chung Hang Jonathan Choi; Wing Yin Tong; Nicolas H Voelcker
Journal:  Adv Sci (Weinh)       Date:  2022-07-18       Impact factor: 17.521

2.  Size and charge dual-transformable mesoporous nanoassemblies for enhanced drug delivery and tumor penetration.

Authors:  Liang Chen; Tiancong Zhao; Mengyao Zhao; Wenxing Wang; Caixia Sun; Lu Liu; Qin Li; Fan Zhang; Dongyuan Zhao; Xiaomin Li
Journal:  Chem Sci       Date:  2020-02-03       Impact factor: 9.825

Review 3.  Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration.

Authors:  Zimu Li; Xiaoting Shan; Zhidong Chen; Nansha Gao; Wenfeng Zeng; Xiaowei Zeng; Lin Mei
Journal:  Adv Sci (Weinh)       Date:  2020-11-27       Impact factor: 16.806

4.  pH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer.

Authors:  Chao Li; Yifan Wang; Shuo Zhang; Jiaojiao Zhang; Fang Wang; Yunhao Sun; Lirong Huang; Wen Bian
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

5.  Self-assembled ternary hybrid nanodrugs for overcoming tumor resistance and metastasis.

Authors:  Xu Cheng; Dapeng Li; Jiaxi Xu; Bing Wei; Qin Fang; Longshun Yang; Yanbing Xue; Xin Wang; Rupei Tang
Journal:  Acta Pharm Sin B       Date:  2021-04-02       Impact factor: 11.413

6.  TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy.

Authors:  Guiying Jiang; Xueqian Wang; Ying Zhou; Chenming Zou; Ling Wang; Wei Wang; Danya Zhang; Hanjie Xu; Jie Li; Fei Li; Danfeng Luo; Xiangyi Ma; Ding Ma; Songwei Tan; Rui Wei; Ling Xi
Journal:  Int J Nanomedicine       Date:  2021-06-15

7.  Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy.

Authors:  Xinyi Zhang; Tiantian Zhu; Yaxin Miao; Lu Zhou; Weifang Zhang
Journal:  J Nanobiotechnology       Date:  2020-09-24       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.